◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY

Alembic Pharmaceuticals Limited (APLLTD) Financial History

Name: Alembic Pharmaceuticals Limited (APLLTD) financial statement history
Creator: TickerBase
License: https://creativecommons.org/licenses/by/4.0/

4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

Healthcare · Drug Manufacturers - Specialty & Generic · DATA UPDATED 2026-09-20

Alembic Pharmaceuticals Limited (APLLTD) operates in the Drug Manufacturers - Specialty & Generic industry and is headquartered in Vadodara, India with about 17,244 employees. Its market capitalization is roughly ₹166 billion. In the fiscal year ended 2026-03-31, APLLTD reported ₹72.1B in revenue and ₹6.7B in net income.

Alembic Pharmaceuticals Limited, an integrated pharmaceutical company, develops, manufactures, markets, and sells pharmaceutical products in India and internationally.

Interactive charts & full statements →

APLLTD Revenue & Earnings History — Annual Income Statement

Income statement	2026-03-31	2025-03-31	2024-03-31	2023-03-31	2022-03-31
Total Revenue	₹72.1B	₹65.4B	₹61.1B	₹55.0B	—
Gross Profit	₹48.5B	₹44.0B	₹41.1B	₹34.8B	—
Operating Income (EBIT)	₹8.0B	₹7.4B	₹6.6B	₹4.4B	—
Net Income	₹6.7B	₹5.8B	₹6.2B	₹3.4B	—

INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

APLLTD Quarterly Revenue & Earnings — Last 8 Quarters

Quarterly income statement	2026-06-30	2026-03-31	2025-12-31	2025-06-30	2025-03-31
Total Revenue	₹21.5B	₹18.5B	₹18.8B	₹17.1B	₹17.7B
Gross Profit	₹15.3B	₹13.2B	₹13.5B	₹13.0B	₹12.4B
Operating Income (EBIT)	₹2.3B	₹1.4B	₹2.1B	₹2.1B	₹2.0B
Net Income	₹1.7B	₹2.0B	₹1.3B	₹1.5B	₹1.6B

INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

APLLTD Free Cash Flow History

Cash flow	2026-03-31	2025-03-31	2024-03-31	2023-03-31	2022-03-31
Dividends Paid	(₹2.2B)	(₹2.2B)	(₹1.6B)	(₹2.0B)	—

INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

APLLTD Balance Sheet History

Balance sheet	2026-03-31	2025-03-31	2024-03-31	2023-03-31	2022-03-31
Total Assets	₹87.6B	₹77.7B	₹64.5B	₹61.8B	—
Total Liabilities	₹30.9B	₹25.8B	₹16.3B	₹18.1B	—

INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive APLLTD viewer.

Other Companies in Drug Manufacturers - Specialty & Generic

ASTRAZEN · AstraZeneca Pharma India Limited — ₹169 billion
JUBLPHARMA · Jubilant Pharmova Limited — ₹169 billion
4547 · Kissei Pharmaceutical Co., Ltd. — JPY 168 billion
COHANCE · Cohance Lifesciences Limited — ₹168 billion
4521 · Kaken Pharmaceutical Co., Ltd. — JPY 151 billion
NATCOPHARM · NATCO Pharma Limited — ₹148 billion
SUDEEPPHRM · Sudeep Pharma Limited — ₹130 billion
AKUMS · Akums Drugs and Pharmaceuticals Limited — ₹120 billion

← APLI All “A” companies APLM →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.